clinical trial · NCT07443202
Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)
Ocular RosacealotilanerVehicle
brief summary
To evaluate lotilaner treatment in patients with ocular rosacea.
started
Dec 5, 2025
primary completion
Dec 31, 2026
completion
Dec 31, 2027
last updated
Mar 2, 2026
detailed description
To evaluate safety of lotilaner compared to vehicle control in the treatment of ocular rosacea.
official title
A Randomized, Vehicle-Controlled, Multicenter, Double-Masked, Parallel, Phase 2 Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of Lotilaner Ophthalmic Gel in Participants With Ocular Rosacea (KORE)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol